Lucas Schoenfeldt is a researcher who recently completed his PhD at the University of Lausanne. His work focuses on reversing cellular ageing using chemical reprogramming. He co-authored a major study showing that a two-chemical cocktail can rejuvenate aged human cells and extend lifespan in worms by 42%. Lucas also works with EPITERNA, a biotech startup exploring anti-ageing therapies. His research avoids risky genetic methods and uses small molecules for safer, reversible treatments. Lucas aims to develop practical ways to slow or reverse ageing and improve healthspan, potentially transforming future approaches to age-related diseases and regenerative medicine.